S. Aaron

Young Woong Kim, William H. Yang, L. Liang, 2016, Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology.

Overdiagnosis of asthma in obese and nonobese adults

L. Boulet, C. Lemière, S. Field, 2008, Canadian Medical Association Journal.

Reasons and outcomes for patients receiving ICS/LABA agents prior to, and one month after, emergency department presentations for acute asthma

I. Stiell, B. Rowe, S. Majumdar, 2018, The Journal of asthma : official journal of the Association for the Care of Asthma.

Increased prevalence of colonic adenomas in patients with cystic fibrosis.

S. Aaron, R. Goel, P. James, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Identification and definition of asthma–COPD overlap: The CanCOLD study

F. Maltais, J. Bourbeau, D. Sin, 2020, Respirology.

Effect of theophylline on exercise capacity in COPD patients treated with combination long-acting bronchodilator therapy: a pilot study

S. Aaron, E. Sabri, G. Alvarez, 2012, International journal of chronic obstructive pulmonary disease.

Effects of oxygen on exercise duration in chronic obstructive pulmonary disease patients before and after pulmonary rehabilitation.

S. Aaron, D. Fergusson, E. Sabri, 2010, Canadian respiratory journal.

Should we avoid β-agonists for moderate and severe chronic obstructive pulmonary disease?: YES

S. Aaron, 2007 .

Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction.

S. Aaron, R. Dales, J. Clinch, 2006, Chest.

Randomized Trial of a Decision Aid for Cystic Fibrosis Patients Considering Lung Transplantation

P. Bye, A. O'Connor, S. Aaron, 2009 .

Molecular epidemiology of Mycobacterium tuberculosis to describe the transmission dynamics among Inuit residing in Iqaluit Nunavut using whole genome sequencing.

M. Behr, S. Aaron, S. Pakhalé, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials.

S. Aaron, R. Dales, R. G. Stoodley, 1999, Annals of emergency medicine.

Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis

S. Doucette, S. Aaron, A. Freitag, 2011, Thorax.

Effect of type and dosage of newly prescribed inhaled corticosteroids on obstructive lung disease and pneumonia hospitalisations in older individuals with asthma, COPD or both: a retrospective study of health administrative data

T. To, M. Stanbrook, J. Bourbeau, 2020, European Respiratory Journal.

Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT).

L. Gula, G. Wells, S. Aaron, 2019, American heart journal.

Inhibition of exhaled nitric oxide production during sepsis does not prevent lung inflammation.

Arthur S Slutsky, G. Volgyesi, T. Stewart, 1998, Critical care medicine.

Methodological issues in therapeutic trials of COPD

S. Suissa, P. Ernst, S. Aaron, 2008, European Respiratory Journal.

METHODOLOGICAL ISSUES IN THERAPEUTIC TRIALS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

S. Suissa, S. Aaron, P. Ernst, 2008 .

Bronchodilators are central to the management of stable chronic obstructive pulmonary disease in the elderly

D. D. Briggs, P. Calverley, E. Bateman, 2010 .

Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.

Meilan K. Han, J. Curtis, W. Bailey, 2014, The New England journal of medicine.

The Canadian Respiratory Research Network (CRRN): Past, present and future

S. Aaron, A. Gershon, K. Vandemheen, 2022, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.

Reaching for the Holy Grail of Chronic Obstructive Pulmonary Disease Outcomes. Can Medications Modify Lung Function Decline?

S. Aaron, 2018, American journal of respiratory and critical care medicine.

Impact of marijuana smoking on lung function in older persons

J. Bourbeau, D. Sin, S. Aaron, 2020, European Respiratory Journal.

Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department

A. Forster, I. Stiell, B. Rowe, 2018, Canadian Medical Association Journal.

Disease burden in individuals with symptomatic undiagnosed asthma or COPD.

G. A. Whitmore, L. Boulet, C. Lemière, 2022, Respiratory medicine.

Factors associated with undiagnosed and overdiagnosed COPD

T. To, M. Stanbrook, J. Bourbeau, 2016, European Respiratory Journal.

Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study

F. Maltais, J. Bourbeau, D. Sin, 2014 .

Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study

F. Maltais, J. Bourbeau, D. Sin, 2013 .

A first step to STOP cystic fibrosis exacerbations.

P. Burgel, S. Aaron, D. Reid, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Antibiotic Retreatment for Acute Exacerbations of Chronic Obstructive Pulmonary Disease

S. Aaron, S. Sethi, 2020, American Journal of Respiratory and Critical Care Medicine.

Influence of country-level differences on COPD prevalence

S. Aaron, A. Gershon, Yuan Gao, 2016, International journal of chronic obstructive pulmonary disease.

Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities

S. Aaron, 2014, European Respiratory Journal.

COPD_A_338849 3275..3284

Delvina Hasimja, D. MacFadden, S. Aaron, 2021 .

Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations

S. Aaron, K. Thavorn, G. Alvarez, 2018, Pilot and Feasibility Studies.

Spirometry in Bronchial Asthma: Response

T. To, S. Aaron, A. Gershon, 2012 .

COPD exacerbations: predicting the future from the recent past.

S. Aaron, 2009, American journal of respiratory and critical care medicine.

Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD

G. A. Whitmore, S. Aaron, 2020, European Respiratory Journal.

Impact of respiratory viral infections on mortality and critical illness among hospitalized patients with chronic obstructive pulmonary disease

A. Forster, M. Andrew, S. Aaron, 2022, Influenza and other respiratory viruses.

How accurate is spirometry at predicting restrictive pulmonary impairment?

S. Aaron, R. Dales, P. Cardinal, 1999, Chest.

Management of malignant pleural effusions with indwelling pleural catheters or talc pleurodesis.

A. Forster, S. Aaron, N. Srour, 2013, Canadian respiratory journal.

Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.

K. Wright, S. Aaron, R. Dales, 2001, American journal of respiratory and critical care medicine.

Effects of CPAP on Blood Pressure and Sympathetic Activity in Patients With Diabetes Mellitus, Chronic Kidney Disease, and Resistant Hypertension

G. Knoll, S. Aaron, J. Leech, 2020, CJC open.

Trends in COPD Prevalence, Incidence and Health Services Use in Younger Adults

S. Aaron, T. Kendzerska, J. Luo, 2019, D102. OPTIMIZING OUTCOMES IN COPD.

Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis

S. Aaron, K. Ramotar, R. Saginur, 2004, European Respiratory Journal.

CLEP_A_308852 453..467

S. Aaron, M. Povitz, D. McIsaac, 2021 .

Reassessment of an Asthma Diagnosis-Reply.

S. Aaron, 2017, JAMA.

Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation.

S. Aaron, R. Brison, P. Hebert, 2002, Chest.

Avoiding mistakes in calculating the number needed to treat in severe COPD.

S. Aaron, 2007, American journal of respiratory and critical care medicine.

[Canadian Thoracic Society COPD guidelines: summary of highlights for family doctors].

F. Maltais, J. Bourbeau, G. Ford, 2003, Canadian respiratory journal.

Reply to Bergl: Diagnostic Failures in Asthma.

S. Aaron, 2019, American journal of respiratory and critical care medicine.

Mucolytics for COPD: negotiating a slippery slope towards proof of efficacy

S. Aaron, 2017, European Respiratory Journal.

A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD

Delvina Hasimja, D. MacFadden, S. Aaron, 2021, International Journal of Chronic Obstructive Pulmonary Disease.

Trends in Chronic Obstructive Pulmonary Disease Prevalence, Incidence, and Health Services Use in Younger Adults in Ontario, Canada, 2006 to 2016.

T. To, S. Aaron, A. Gershon, 2020, American journal of respiratory and critical care medicine.

Management of steroid-dependent asthma with methotrexate: a meta-analysis of randomized clinical trials.

B. Pham, S. Aaron, R. Dales, 1998, Respiratory medicine.

WS17.6 Phase 3 trial of inhaled levofloxacin (Aeroquin™, MP-376, APT-1026) vs. tobramycin inhalation solution (TIS) in intensively treated CF patients over 6 months

R. Fischer, E. Kerem, S. Aaron, 2013 .

Low Molecular Weight Heparin Decreases Proximal and Distal Deep Venous Thrombosis Following Total Knee Arthroplasty

S. Aaron, A. Howard, A. Howard, 1998, Thrombosis and Haemostasis.

Trends in all‐cause mortality and inpatient and outpatient visits for ambulatory care sensitive conditions during the first year of the COVID‐19 pandemic: A population‐based study

T. Stukel, D. Manuel, S. Aaron, 2022, Journal of hospital medicine.

Treatment of Aspergillus fumigatus in Patients with Cystic Fibrosis: A Randomized, Placebo-Controlled Pilot Study

S. Aaron, A. Freitag, E. Tullis, 2012, PloS one.

The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis.

S. Aaron, F. Ratjen, A. Dupuis, 2010, Chest.

Comparative Genomics of Isolates of a Pseudomonas aeruginosa Epidemic Strain Associated with Chronic Lung Infections of Cystic Fibrosis Patients

J. Jeukens, I. Kukavica-Ibrulj, N. Tucker, 2014, PloS one.

Effect of infection with transmissible strains of Pseudomonas aeruginosa on lung transplantation outcomes in patients with cystic fibrosis.

S. Keshavjee, S. Aaron, N. Srour, 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Chronic Obstructive Pulmonary Disease: Possible Confounding Effect of Treatment Withdrawal?

S. Aaron, 2007 .

N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE study.

S. Kahn, A. Hirsch, A. Akaberi, 2017, Thrombosis research.

Dyspnea, Quality of Life and Walking Capacity during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Results of the E.L.O.P.E. Study

S. Kahn, A. Hirsch, A. Akaberi, 2015 .

The Feasibility of the Interferon Gamma Release Assay and Predictors of Discordance with the Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in a Remote Aboriginal Community

S. Aaron, G. Alvarez, R. Mallick, 2014, PloS one.

Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study

F. Maltais, J. Bourbeau, D. Sin, 2017, European Respiratory Journal.

Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations

S. Aaron, T. Mah, K. Vandemheen, 2014, Journal of Cystic Fibrosis.

TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial

F. Maltais, J. Bourbeau, D. Sin, 2012, Thorax.

Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa.

S. Aaron, N. MacDonald, P. Hebert, 2000, American journal of respiratory and critical care medicine.

Multiple Combination Bactericidal Testing of Staphylococcal Biofilms from Implant-Associated Infections

S. Aaron, K. Ramotar, R. Saginur, 2006, Antimicrobial Agents and Chemotherapy.

Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD

P. Jones, S. Sullivan, P. Jones, 2008, Thorax.

Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms.

S. Aaron, I. Gaboury, W. Ferris, 2006, Diagnostic microbiology and infectious disease.

The Use of Ipratropium Bromide for the Management of Acute Asthma Exacerbation in Adults and Children: A Systematic Review

S. Aaron, 2001, The Journal of asthma : official journal of the Association for the Care of Asthma.

Antagonistic interactions peak at intermediate genetic distance in clinical and laboratory strains of Pseudomonas aeruginosa

R. Dali, R. Kassen, S. Aaron, 2012, BMC Microbiology.

Epidemiological investigation and glycotyping of clinical Pseudomonas aeruginosa isolates from patients with cystic fibrosis by mass spectrometry: association with multiple drug resistance.

Xin Liu, Jianjun Li, S. Aaron, 2009, Journal of microbiological methods.

Multiple Combination Bactericidal Testing

S. Aaron, R. Saginur, W. Ferris, 2007 .

Prospective and Explicit Clinical Validation of the Ottawa Heart Failure Risk Scale, With and Without Use of Quantitative NT‐proBNP

A. Forster, I. Stiell, B. Rowe, 2017, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events.

A. Forster, I. Stiell, B. Rowe, 2013, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation

A. Wong, S. Aaron, Julie Joseph, 2016, The Journal of Immunology.

Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee

I. Pavord, J. Wedzicha, G. Washko, 2019, Annals of the American Thoracic Society.

Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis.

G. A. Whitmore, S. Stanojevic, S. Aaron, 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Topical tetracaine prior to arterial puncture: a randomized, placebo-controlled clinical trial.

M. Rodger, S. Aaron, K. Vandemheen, 2003, Respiratory medicine.

Canadian prediction equations of spirometric lung function for Caucasian adults 20 to 90 years of age: results from the Canadian Obstructive Lung Disease (COLD) study and the Lung Health Canadian Environment (LHCE) study.

F. Maltais, J. Bourbeau, D. Sin, 2011, Canadian respiratory journal.

Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline

J. Wedzicha, G. Washko, F. Martinez, 2020, American journal of respiratory and critical care medicine.

TAIMA (Stop) TB: The Impact of a Multifaceted TB Awareness and Door-to-Door Campaign in Residential Areas of High Risk for TB in Iqaluit, Nunavut

S. Aaron, K. Moreau, G. Alvarez, 2014, PloS one.

Effect of implementation of a 12 dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series design.

J. Grimshaw, M. Taljaard, H. Alsdurf, 2022, International Journal of Infectious Diseases.

Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis.

R. Chernish, S. Aaron, Shawn D Aaron, 2003, Current opinion in pulmonary medicine.

Development and external validation of 1- and 2-year mortality prediction models in cystic fibrosis

G. A. Whitmore, S. Stanojevic, S. Aaron, 2019, European Respiratory Journal.

Development of a decision aid for adult cystic fibrosis patients considering referral for lung transplantation.

Annette O'Connor, A. O'Connor, S. Aaron, 2010, Progress in transplantation.

"Placebo Effects" in Clinical Trials Evaluating Patients with Uncontrolled Persistent Asthma.

G. A. Whitmore, S. Aaron, P. Gibson, 2019, Annals of the American Thoracic Society.

Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with COPD and/or Asthma: A Population Study.

T. To, M. Stanbrook, J. Bourbeau, 2019, Annals of the American Thoracic Society.

Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study.

F. Maltais, J. Bourbeau, D. Sin, 2019, Respiratory medicine.

Ten‐year trends in direct costs of asthma: a population‐based study

L. Lynd, S. Aaron, C. Marra, 2016, Allergy. European Journal of Allergy and Clinical Immunology.

Specialist Care in Individuals with Asthma Who Required Hospitalization: A Retrospective Population-Based Study.

T. To, S. Aaron, M. Lougheed, 2021, The journal of allergy and clinical immunology. In practice.

Pulmonary function testing in the diagnosis of asthma: a population study.

T. To, S. Aaron, A. Gershon, 2012, Chest.

CTS position statement: Pharmacotherapy in patients with COPD—An update

M. Beauchesne, F. Maltais, J. Bourbeau, 2017 .

Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults.

Benjamin M. Smith, R. Kronmal, E. Hoffman, 2020, JAMA.

of COPD in randomised controlled trials Counting, analysing and reporting exacerbations

G. Marks, S. Aaron, R. Goldstein, 2008 .

Tiotropium in Combination with Placebo, Salmeterol, or FluticasoneSalmeterol for Treatment of Chronic Obstructive Pulmonary Disease

J. Bourbeau, S. Field, G. Ford, 2007, Annals of Internal Medicine.

The Acute COPD Exacerbation Prediction Tool (ACCEPT): development and external validation study of a personalised prediction model

D. Sin, S. Aaron, M. Sadatsafavi, 2019 .

Management and prevention of exacerbations of COPD

S. Aaron, 2014, BMJ : British Medical Journal.

Chronic Obstructive Pulmonary Disease Exacerbations: Current Controversies

S. Aaron, 2019, Barcelona Respiratory Network.

Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.

I. Stiell, B. Rowe, G. Wells, 2003, The New England journal of medicine.

Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease--practical issues: a Canadian Thoracic Society Clinical Practice Guideline.

D. Brooks, F. Maltais, J. Bourbeau, 2010, Canadian respiratory journal.

Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease

L. Boulet, J. Bourbeau, D. Sin, 2018, American journal of respiratory and critical care medicine.

Health Services Burden of Undiagnosed and Overdiagnosed COPD

T. To, M. Stanbrook, J. Bourbeau, 2018, Chest.

Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence

M. Beauchesne, F. Maltais, J. Bourbeau, 2019, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.

Dyspnoea and symptom burden in mild–moderate COPD: the Canadian Cohort Obstructive Lung Disease Study

F. Maltais, J. Bourbeau, D. Sin, 2021, ERJ Open Research.

Bronchodilator Responsiveness and Reported Respiratory Symptoms in an Adult Population

A. Buist, F. Maltais, J. Bourbeau, 2013, PloS one.

Smoking and smoking cessation among people with chronic obstructive pulmonary disease (COPD)

T. To, S. Aaron, A. Gershon, 2019 .

Outcomes of patients with chronic obstructive pulmonary disease diagnosed with or without pulmonary function testing

T. To, M. Stanbrook, Graham C. Mecredy, 2017, Canadian Medical Association Journal.

Triple Therapy versus Dual or Monotherapy with Long-acting Bronchodilators for COPD: A Systematic Review and Meta-Analysis.

S. Aaron, L. Nici, M. Mammen, 2020, Annals of the American Thoracic Society.

The prevalence of airflow obstruction in rural primary care.

S. Aaron, R. Dales, J. Clinch, 2006, Respiratory medicine.

State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease.

D. Brooks, R. Abboud, N. Choudry, 2004, Canadian respiratory journal.

Quality Assurance of Spirometry in a Population-Based Study –Predictors of Good Outcome in Spirometry Testing

F. Maltais, J. Bourbeau, D. Sin, 2014, COPD.

Physiological changes during symptom recovery from moderate exacerbations of COPD

S. Aaron, D. O’Donnell, K. Webb, 2005, European Respiratory Journal.

Evaluation of a decision aid for making choices about intubation and mechanical ventilation in chronic obstructive pulmonary disease.

Paul C Hébert, Keith G Wilson, Ian D Graham, 2005, Patient education and counseling.

What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement

V. Kim, S. Aaron, 2018, European Respiratory Journal.

Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study

A. Buist, F. Maltais, J. Bourbeau, 2014, Thorax.

Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study

J. Hogg, A. Buist, J. Leipsic, 2015, Thorax.

CT imaging of chronic obstructive pulmonary disease: insights, disappointments, and promise.

G. Washko, H. Coxson, S. Aaron, 2017, The Lancet. Respiratory medicine.

Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial

Y. Lacasse, F. Maltais, F. Sériès, 2017, BMC Pulmonary Medicine.

Incident diuretic drug use and adverse respiratory events among older adults with chronic obstructive pulmonary disease

T. To, P. Austin, S. Aaron, 2017, British journal of clinical pharmacology.

Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the Need for Longitudinal Observational Studies in COPD

Andrea Benedetti, Don D. Sin, Shawn D. Aaron, 2014, COPD.

Cardiovascular Outcomes and All‐Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome)

N. Ayas, S. Aaron, A. Gershon, 2019, Annals of the American Thoracic Society.

The impact of a history of asthma on long‐term outcomes of people with newly diagnosed chronic obstructive pulmonary disease: A population study

T. To, S. Aaron, M. Sadatsafavi, 2017, The Journal of allergy and clinical immunology.

Effect of weight reduction on respiratory function and airway reactivity in obese women.

S. Aaron, R. Dales, Yue Chen, 2004, Chest.

Evaluating nocturnal oxygen desaturation in COPD--revised.

Yves Lacasse, François Maltais, Y. Lacasse, 2011, Respiratory medicine.

Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study

J. Leipsic, F. Maltais, J. Bourbeau, 2016, PloS one.

Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study

F. Maltais, B. Miller, J. Brook, 2022, American Journal of Respiratory and Critical Care Medicine.

The effects of marijuana smoking on lung function in older people

T. To, F. Maltais, J. Bourbeau, 2019, European Respiratory Journal.

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori

Eun Chong Lee, F. Martinez, J. Connett, 2017, Respiratory Research.

Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease.

Y. Lacasse, F. Maltais, J. Bourbeau, 2020, The New England journal of medicine.

Time course and pattern of COPD exacerbation onset

G. A. Whitmore, J. Wedzicha, G. Donaldson, 2011, Thorax.

Breathlessness catastrophizing relates to poorer quality of life in adults with cystic fibrosis.

S. Aaron, S. Pakhalé, G. Tasca, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Assessment of stigma in patients with cystic fibrosis

S. Aaron, S. Pakhalé, G. Tasca, 2014, BMC Pulmonary Medicine.

Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for COPD: A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline.

S. Aaron, W. Alhazzani, L. Nici, 2020, Annals of the American Thoracic Society.

Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study

F. Maltais, J. Bourbeau, D. Sin, 2022, American journal of respiratory and critical care medicine.

An Updated Definition and Severity Classification of COPD Exacerbations: The Rome Proposal.

J. Wedzicha, M. Humbert, R. Rodríguez-Roisín, 2021, American journal of respiratory and critical care medicine.

A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory.

S. Aaron, R. Dales, J. Clinch, 2003, Chest.

A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease

S. Hawken, S. Aaron, C. Cameron, 2015, PloS one.

Canadian Thoracic Society COPD Guidelines: summary of highlights for family doctors.

F. Maltais, J. Bourbeau, G. Ford, 2003, Canadian respiratory journal.

Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study

A. Forster, I. Stiell, B. Rowe, 2014, Canadian Medical Association Journal.

The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study

F. Maltais, J. Bourbeau, D. Sin, 2021, International journal of chronic obstructive pulmonary disease.

The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study

F. Maltais, J. Bourbeau, D. Sin, 2021 .

Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-Analysis.

W. Bailey, R. Casaburi, F. Martinez, 2020, Chest.

Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study.

S. Kahn, A. Hirsch, A. Akaberi, 2017, The American journal of medicine.

Long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus either agent alone or placebo for chronic obstructive pulmonary disease

D. Sin, S. Aaron, J. FitzGerald, 2014 .

Prescription Pathways from Initial Medication Use to Triple Therapy in Older COPD Patients: A Real-World Population Study

M. Stanbrook, T. Stukel, S. Aaron, 2022, COPD.

Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study.

F. Maltais, A. Malhotra, N. Ayas, 2019, Chest.

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)

J. Curtis, W. Bailey, R. Casaburi, 2017, Respiratory Research.

Cost-effectiveness of implementing objective diagnostic verification of asthma in the United States.

M. Yaghoubi, S. Aaron, M. Sadatsafavi, 2019, The Journal of allergy and clinical immunology.

Case-Ascertainment Models to Identify Adults with Obstructive Sleep Apnea Using Health Administrative Data: Internal and External Validation

C. van Walraven, S. Aaron, M. Povitz, 2021, Clinical epidemiology.

Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa

R. Kassen, S. Aaron, J. Dettman, 2013, Proceedings of the National Academy of Sciences.

Identifying Clinical Research Priorities in Adult Pulmonary and Critical Care: NHLBI Working Group Report.

D. Needham, W. Self, C. Seymour, 2020, American journal of respiratory and critical care medicine.

Influence of prolonged treatment with omalizumab on the development of solid epithelial cancer in patients with atopic asthma and chronic idiopathic urticaria: A systematic review and meta‐analysis

G. Wells, S. Aaron, S. Kelly, 2019, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

A clinical tool to calculate post‐transplant survival using pre‐transplant clinical characteristics in adults with cystic fibrosis

G. A. Whitmore, S. Stanojevic, S. Aaron, 2017, Clinical transplantation.

Persistent hypoxemia occurring as a complication of tricuspid valve endocarditis.

S. Aaron, M. Turek, M. Brais, 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.

S. Doucette, S. Aaron, A. Freitag, 2010, JAMA.

Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada.

S. Aaron, T. Mah, K. Vandemheen, 2010, Canadian journal of microbiology.

Randomized trial of a decision aid for patients with cystic fibrosis considering lung transplantation.

Gerard Ryan, Peter Gibson, Peter Bye, 2009, American journal of respiratory and critical care medicine.

Moving beyond AUC: decision curve analysis for quantifying net benefit of risk prediction models.

D. Sin, M. Puhan, S. Aaron, 2021, European Respiratory Journal.

The Hidden and Unchecked Judgement Calls When Using Exacerbation History for Managing COPD.

D. Sin, M. Puhan, S. Aaron, 2021, Archivos de bronconeumologia.

Socioeconomic status (SES) and 30-day hospital readmissions for chronic obstructive pulmonary (COPD) disease: A population-based cohort study

T. To, M. Stanbrook, D. Thiruchelvam, 2019, PloS one.

Sleep Quality and Nocturnal Symptoms in a Community-Based COPD Cohort

A. Malhotra, N. Ayas, S. Aaron, 2020, COPD.

Post-Pulmonary Embolism Syndrome after a First Episode of PE: Results of the E.L.O.P.E. Study

S. Kahn, A. Hirsch, A. Akaberi, 2015 .

Barriers and Enablers to Objective Testing for Asthma and COPD in Primary Care: A Systematic Review Using the Theoretical Domains Framework.

S. Aaron, Myriam E Gagné, A. Gershon, 2021, Chest.

Physicians' intentions and use of three patient decision aids

Annette M. O'Connor, Paul Hebert, Ian D. Graham, 2007, BMC Medical Informatics Decis. Mak..

Lost in translation? How adults living with Cystic Fibrosis understand treatment recommendations from their healthcare providers, and the impact on adherence to therapy.

S. Aaron, S. Pakhalé, L. Balfour, 2016, Patient education and counseling.

Referral to lung transplantation--too little, too late.

S. Aaron, C. Chaparro, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in Canada.

S. Aaron, S. Pakhalé, G. Alvarez, 2015, Chest.

Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis.

E. Springman, S. Aaron, V. Lucidi, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations.

S. Aaron, T. Mah, K. Ramotar, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Walking a tightrope: targeting neutrophils to treat chronic obstructive pulmonary disease.

S. Aaron, 2015, American journal of respiratory and critical care medicine.

Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD

F. Martinez, J. Connett, G. Criner, 2018, Respiratory Research.

Rates and correlates of relapse following ED discharge for acute asthma: a Canadian 20-site prospective cohort study.

I. Stiell, B. Rowe, S. Majumdar, 2015, Chest.

Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis

S. Aaron, K. Vandemheen, L. Dales, 2009, European Journal of Clinical Microbiology & Infectious Diseases.

Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice

J. Wedzicha, R. Brook, M. Humbert, 2023, American journal of respiratory and critical care medicine.

Concomitant pulmonologist and primary care for chronic obstructive pulmonary disease: a population study

P. Austin, Ross Upshur, S. Aaron, 2017, Family practice.

Addressing the misdiagnosis of asthma in adults: where does it go wrong?

S. Aaron, Robyn H Loves, Jenna MacNeil, 2016, Expert review of respiratory medicine.

Pyrosequencing of a recA gene variable region for Burkholderia cepacia complex genomovar identification.

S. Aaron, K. Ramotar, Liying Yan, 2007, Diagnostic microbiology and infectious disease.

Hospital Resource Utilization and Patient Outcomes Associated with Respiratory Viral Testing in Hospitalized Patients

A. Forster, S. Aaron, P. Ronksley, 2015, Emerging infectious diseases.

Short-term air pollution exposure and exacerbation events in mild to moderate COPD: a case-crossover study within the CanCOLD cohort

F. Maltais, A. Benedetti, P. Hernandez, 2023, Thorax.

A statistical model to predict one-year risk of death in patients with cystic fibrosis.

G. A. Whitmore, S. Aaron, Anne L Stephenson, 2015, Journal of clinical epidemiology.

Factors Associated With Nonreceipt of Recommended COPD Medications

M. Stanbrook, S. Aaron, W. Tan, 2021, Chest.

Calming Nervous Airways: Targeted Lung Denervation for Chronic Obstructive Pulmonary Disease

S. Aaron, D. Mahler, 2019, American Journal of Respiratory and Critical Care Medicine.

Development and psychometric validation of a cystic fibrosis knowledge scale

S. Aaron, S. Pakhalé, L. Balfour, 2014, Respirology.

The COPD Assessment Test: Can It Discriminate Across COPD Subpopulations?

F. Maltais, J. Bourbeau, D. Sin, 2016, Chest.

A comparison of obese and nonobese people with asthma: exploring an asthma-obesity interaction.

L. Boulet, C. Lemière, S. Field, 2010, Chest.

Routine lung volume recruitment in boys with Duchenne muscular dystrophy: a randomised clinical trial

M. Tarnopolsky, D. Wensley, S. Aaron, 2022, Thorax.

Asthma-Obesity Interaction People With Asthma : Exploring an A Comparison of Obese and Nonobese

C. Lemière, S. Field, S. Doucette, 2010 .

Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis

S. Aaron, D. Guttman, Y. Yau, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Factors Associated with Attrition in a Longitudinal Cohort of Older Adults in the Community.

F. Maltais, P. Hernandez, S. Aaron, 2023, Chronic obstructive pulmonary diseases.

Persistency of Pseudomonas aeruginosa in sputum cultures and clinical outcomes in adult patients with cystic fibrosis

S. Aaron, D. Fergusson, K. Ramotar, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Development of quality indicators for chronic obstructive pulmonary disease (COPD): A modified RAND appropriateness method

T. To, Graham C. Mecredy, P. Hernandez, 2018, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.

Medication Discontinuation in Adults with Chronic Obstructive Pulmonary Disease Discharged from Hospital: A Population-Based Cohort Study.

T. To, C. Bell, D. Thiruchelvam, 2020, Chest.

Medication Discontinuation in Adults With COPD Discharged From the Hospital

T. To, C. Bell, D. Thiruchelvam, 2020 .

Factors Affecting Health Literacy as Related to Asthma and COPD Management: Learning from Patient and Health Care Professional Viewpoints

K. Lavoie, S. Aaron, Samir Gupta, 2021, Health literacy research and practice.

Calming Nervous Airways: Targeted Lung Denervation for Chronic Obstructive Pulmonary Disease

S. Aaron, D. Mahler, 2019, American journal of respiratory and critical care medicine.

Association between opioid prescription profiles and adverse health outcomes in opioid users referred for sleep disorder assessment: a secondary analysis of health administrative data

A. Malhotra, S. Aaron, M. Povitz, 2023, Frontiers in Sleep.

Evaluating nocturnal oxygen desaturation in COPD--revised.

Y. Lacasse, F. Maltais, J. Bourbeau, 2011, Respiratory medicine.

Tiotropium in Combination with Placebo, Salmeterol, or FluticasoneSalmeterol for Treatment of Chronic Obstructive Pulmonary Disease

J. Bourbeau, S. Field, G. Ford, 2007, Annals of Internal Medicine.

A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients.

R. Fischer, E. Kerem, S. Aaron, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Patients as research partners in chronic obstructive pulmonary disease and asthma research: Priorities, challenges and recommendations from asthma and COPD patients

T. To, L. Boulet, K. Lavoie, 2018 .

Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study.

F. Maltais, J. Bourbeau, D. Sin, 2019, Respiratory medicine.

Outcomes and Resource Utilization Among Patients Admitted to the Intensive Care Unit Following Acute Exacerbation of Chronic Obstructive Pulmonary Disease

B. Rochwerg, S. Fernando, Alexandre Tran, 2020, Journal of intensive care medicine.

Pulmonary function testing in the diagnosis of asthma: a population study.

T. To, S. Aaron, A. Gershon, 2012, Chest.

Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.

M. Elkins, P. Bye, S. Aaron, 2005, Journal of Clinical Microbiology.

FACTORS ASSOCIATED WITH NON-RECEIPT OF RECOMMENDED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MEDICATIONS: A POPULATION STUDY.

M. Stanbrook, S. Aaron, W. Tan, 2021, Chest.